139 related articles for article (PubMed ID: 15569324)
1. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen.
Gealekman O; Brodsky SV; Zhang F; Chander PN; Friedli C; Nasjletti A; Goligorsky MS
Kidney Int; 2004 Dec; 66(6):2337-47. PubMed ID: 15569324
[TBL] [Abstract][Full Text] [Related]
2. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen.
Brodsky SV; Gealekman O; Chen J; Zhang F; Togashi N; Crabtree M; Gross SS; Nasjletti A; Goligorsky MS
Circ Res; 2004 Feb; 94(3):377-84. PubMed ID: 14670841
[TBL] [Abstract][Full Text] [Related]
3. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen.
Chander PN; Gealekman O; Brodsky SV; Elitok S; Tojo A; Crabtree M; Gross SS; Goligorsky MS
J Am Soc Nephrol; 2004 Sep; 15(9):2391-403. PubMed ID: 15339988
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Maquignau M; Loufrani L; Henrion D
Cardiovasc Res; 2009 Mar; 81(4):788-96. PubMed ID: 19050009
[TBL] [Abstract][Full Text] [Related]
5. Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats.
Ito D; Cao P; Kakihana T; Sato E; Suda C; Muroya Y; Ogawa Y; Hu G; Ishii T; Ito O; Kohzuki M; Kiyomoto H
PLoS One; 2015; 10(9):e0138037. PubMed ID: 26379244
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between cardiomyocyte-rich perivascular tissue and coronary arteries is reduced in the Zucker Diabetic Fatty rat model of type 2 diabetes mellitus.
Bonde L; Shokouh P; Jeppesen PB; Boedtkjer E
Acta Physiol (Oxf); 2017 Jan; 219(1):227-238. PubMed ID: 27042951
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.
Toblli JE; Cao G; Giani JF; Angerosa M; Dominici FP; Gonzalez-Cadavid NF
Kidney Blood Press Res; 2011; 34(1):20-33. PubMed ID: 21071958
[TBL] [Abstract][Full Text] [Related]
9. Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy.
Wang H; Zhou Y; Guo Z; Dong Y; Xu J; Huang H; Liu H; Wang W
J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):66-78. PubMed ID: 28618859
[TBL] [Abstract][Full Text] [Related]
10. Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats.
Agil A; Rosado I; Ruiz R; Figueroa A; Zen N; Fernández-Vázquez G
J Pineal Res; 2012 Mar; 52(2):203-10. PubMed ID: 21883445
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats.
Lu X; Guo X; Karathanasis SK; Zimmerman KM; Onyia JE; Peterson RG; Kassab GS
Cardiovasc Diabetol; 2010 May; 9():19. PubMed ID: 20482873
[TBL] [Abstract][Full Text] [Related]
12. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes.
Li X; Zhang L; Meshinchi S; Dias-Leme C; Raffin D; Johnson JD; Treutelaar MK; Burant CF
Diabetes; 2006 Nov; 55(11):2965-73. PubMed ID: 17065332
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats.
Schmid PM; Resch M; Schach C; Birner C; Riegger GA; Luchner A; Endemann DH
Cardiovasc Diabetol; 2013 Mar; 12():46. PubMed ID: 23497197
[TBL] [Abstract][Full Text] [Related]
14. Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
Li Y; Qi Y; Kim MS; Xu KZ; Huang TH; Rong X; Murray M; Yamahara J
Diabetes Metab Res Rev; 2008 Sep; 24(6):498-506. PubMed ID: 18613221
[TBL] [Abstract][Full Text] [Related]
15. Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats.
Togashi Y; Miyamoto Y
Exp Toxicol Pathol; 2013 Jul; 65(5):615-22. PubMed ID: 22795897
[TBL] [Abstract][Full Text] [Related]
16. Capillary endothelial but not lymphatic function is restored under rosiglitazone in Zucker diabetic fatty rats.
Cosson E; Cohen-Boulakia F; Tarhzaoui K; Dabiré H; Léger G; Charnaux N; Lestrade R; Behar A; Valensi P
Microvasc Res; 2009 Mar; 77(2):220-5. PubMed ID: 19109983
[TBL] [Abstract][Full Text] [Related]
17. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats.
Schäfer S; Linz W; Bube A; Gerl M; Huber J; Kürzel GU; Bleich M; Schmidts HL; Busch AE; Rütten H
Cardiovasc Res; 2003 Nov; 60(2):447-54. PubMed ID: 14613875
[TBL] [Abstract][Full Text] [Related]
18. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats.
Oltman CL; Richou LL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1780-7. PubMed ID: 16714356
[TBL] [Abstract][Full Text] [Related]
19. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
[TBL] [Abstract][Full Text] [Related]
20. Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure.
Resch M; Bergler T; Fredersdorf S; Griese DP; Weil J; Kreuzer P; Brunner S; Riegger GA; Luchner A; Endemann DH
Hypertens Res; 2010 Oct; 33(10):1082-8. PubMed ID: 20664544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
